Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2006 - 90 pages - $995
Jan 2011 - 124 pages - $1,740
Apr 2007 - 118 pages - $2,495
Feb 2006 - 332 pages - $3,900
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Jan 2008 - 330 pages - $4,200
Jan 2010 - 250 pages - $3,900
Oct 2011 - 64 pages - $500
Your selection
Browse By
- Therapeutic target
- Auditory
- Opthalmic
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us